摘要: In part because it is amphetamine derived, ecstasy has inherited some of its parent compound's reputation for being neurotoxic. However, whereas and methamphetamine undoubtedly cause irreversible brain damage with long-term use, the jury still out on party drug ecstasy. The deadly been fuelled by tragic fates healthy young clubbers who have died after taking drug. compared other recreational drugs, there very few ecstasy-related deaths. Further, little evidence short-term neurotoxicity at doses. That not to say that leaves user neutral. Chronic use causes depletion serotonin, which subtle but important effects cognition mood. Although seems unlikely we will be faced a generation goers suffer from premature Parkinson's disease, so known about mood, emotional states cognitive function present cannot predict what impact their middle-age average user.
elsevier.com
tamucc.edu 
sci-hub.se 参考文章(58)
Alexander T. Shulgin, History of MDMA Springer, Boston, MA. pp. 1- 20 ,(1990) , 10.1007/978-1-4613-1485-1_1
Mahmoud M. Iravani, Michael J. Jackson, Mikko Kuoppamäki, Lance A. Smith, Peter Jenner, 3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates The Journal of Neuroscience. ,vol. 23, pp. 9107- 9115 ,(2003) , 10.1523/JNEUROSCI.23-27-09107.2003
A. C. Parrott, T. Buchanan, T. M. Heffernan, A. Scholey, J. Ling, J. Rodgers, Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users Psychopharmacology. ,vol. 167, pp. 449- 450 ,(2003) , 10.1007/S00213-003-1447-5
Iain S McGregor, Kelly J Clemens, Geoffrey Van der Plasse, Kong M Li, Glenn E Hunt, Feng Chen, Andrew J Lawrence, Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology. ,vol. 28, pp. 1472- 1484 ,(2003) , 10.1038/SJ.NPP.1300185
A. C. Parrott, J. Rodgers, T. Buchanan, A. B. Scholey, T. Heffernan, J. Ling, The reality of psychomotor problems, and the possibility of Parkinson’s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003) Psychopharmacology. ,vol. 171, pp. 231- 233 ,(2004) , 10.1007/S00213-003-1600-1
Michael A Taffe, Salvador Huitrón-Resendiz, Richard Schroeder, Loren H Parsons, Steven J Henriksen, Lisa H Gold, MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys Pharmacology, Biochemistry and Behavior. ,vol. 76, pp. 141- 152 ,(2003) , 10.1016/S0091-3057(03)00217-X
P. Damier, E. C. Hirsch, Y. Agid, A. M. Graybiel, The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. ,vol. 122, pp. 1437- 1448 ,(1999) , 10.1093/BRAIN/122.8.1437
Linda Quate, Douglas E. McBean, Isobel M. Ritchie, Henry J. Olverman, Paul A. T. Kelly, Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat. Psychopharmacology. ,vol. 173, pp. 287- 295 ,(2004) , 10.1007/S00213-004-1784-Z
Robert Maslansky, None, Metaphors, misuse, and misconceptions. Science. ,vol. 301, pp. 1479- 1482 ,(2003) , 10.1126/SCIENCE.301.5639.1479C
Euphrosyne Gouzoulis-Mayfrank, Bastian Thimm, Markus Rezk, Gernot Hensen, Joerg Daumann, Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users Progress in Neuro-Psychopharmacology and Biological Psychiatry. ,vol. 27, pp. 819- 827 ,(2003) , 10.1016/S0278-5846(03)00114-3